- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Myelofibrosis With High Molecular Risk Mutations in Hong Kong
Total 1 results
-
Novartis PharmaceuticalsTerminatedMyelofibrosis With High Molecular Risk MutationsBelgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland